应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
WXXWY 药明生物ADR
休市中 01-09 16:00:00 EST 延时
资讯
新帖
简况
美国OTC市场药明生物ADR盘中异动 股价大涨5.75%报8.28美元
市场透视 · 2025-11-24
美国OTC市场药明生物ADR盘中异动 股价大涨5.75%报8.28美元
美国OTC市场药明生物ADR盘中异动 早盘急速拉升6.41%报9.63美元
市场透视 · 2025-10-13
美国OTC市场药明生物ADR盘中异动 早盘急速拉升6.41%报9.63美元
美国OTC市场药明生物ADR盘中异动 早盘大幅下挫5.38%报9.84美元
市场透视 · 2025-10-10
美国OTC市场药明生物ADR盘中异动 早盘大幅下挫5.38%报9.84美元
美国OTC市场药明生物ADR盘中异动 股价大涨5.59%报10.58美元
市场透视 · 2025-09-29
美国OTC市场药明生物ADR盘中异动 股价大涨5.59%报10.58美元
药明生物ADR8月11日成交额为3.98万美元
市场透视 · 2025-08-12
药明生物ADR8月11日成交额为3.98万美元
药明生物ADR8月8日成交额为27.78万美元
市场透视 · 2025-08-09
药明生物ADR8月8日成交额为27.78万美元
药明生物ADR8月7日成交额为45.51万美元
市场透视 · 2025-08-08
药明生物ADR8月7日成交额为45.51万美元
美国OTC市场药明生物ADR盘中异动 股价大跌5.26%
市场透视 · 2025-08-07
美国OTC市场药明生物ADR盘中异动 股价大跌5.26%
药明生物ADR8月6日成交额为21.33万美元
市场透视 · 2025-08-07
药明生物ADR8月6日成交额为21.33万美元
药明生物ADR8月5日成交额为11.74万美元
市场透视 · 2025-08-06
药明生物ADR8月5日成交额为11.74万美元
美国OTC市场药明生物ADR盘中异动 早盘股价大涨6.33%
市场透视 · 2025-08-05
美国OTC市场药明生物ADR盘中异动 早盘股价大涨6.33%
药明生物ADR8月4日成交额为10.43万美元
市场透视 · 2025-08-05
药明生物ADR8月4日成交额为10.43万美元
美国OTC市场药明生物ADR盘中异动 急速下跌5.05%
市场透视 · 2025-08-01
美国OTC市场药明生物ADR盘中异动 急速下跌5.05%
药明生物ADR7月31日成交额为11.51万美元
市场透视 · 2025-08-01
药明生物ADR7月31日成交额为11.51万美元
药明生物ADR7月29日成交额为111.64万美元
市场透视 · 2025-07-30
药明生物ADR7月29日成交额为111.64万美元
药明生物ADR7月28日成交额为10.91万美元
市场透视 · 2025-07-29
药明生物ADR7月28日成交额为10.91万美元
药明生物:预计上半年归属权益股东的利润同比增长56%
第一财经 · 2025-07-24
药明生物:预计上半年归属权益股东的利润同比增长56%
美国OTC市场药明生物ADR盘中异动 早盘股价大涨5.15%
市场透视 · 2025-07-17
美国OTC市场药明生物ADR盘中异动 早盘股价大涨5.15%
药明生物ADR7月16日成交额为5.94万美元
市场透视 · 2025-07-17
药明生物ADR7月16日成交额为5.94万美元
药明生物ADR7月14日成交额为8.99万美元
市场透视 · 2025-07-15
药明生物ADR7月14日成交额为8.99万美元
加载更多
公司概况
公司名称:
药明生物ADR
所属市场:
PINK LIMITED
上市日期:
--
主营业务:
药明生物技术有限公司是一家主要从事向生物制剂行业的客户提供就生物发现、开发及生产的端到端解决方案及服务的投资控股公司。该公司主要通过两个分部运营其业务。生物药分部主要从事提供生物药的发现、开发和生产。药明合联(XDC)分部主要从事为抗体偶联药物(ADCs)及各种生物偶联药物提供合同研究、开发及生产组织(CRDMO)服务。该公司主要在国内和国外市场开展其业务。
发行价格:
--
{"stockData":{"symbol":"WXXWY","market":"US","secType":"STK","nameCN":"药明生物ADR","latestPrice":9.55,"timestamp":1767992400000,"preClose":9.37,"halted":0,"volume":32385,"delay":15,"floatShares":1794765667,"shares":2064056990,"eps":0.214998,"marketStatus":"休市中","change":0.18,"latestTime":"01-09 16:00:00 EST 延时","open":9.5,"high":9.58,"low":9.344,"amount":306067.1879,"amplitude":0.025187,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.214998,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768208400000},"marketStatusCode":7,"adr":0,"adrRate":2,"exchange":"PINK LIMITED","adjPreClose":9.37,"volumeRatio":0.8094145540371331},"requestUrl":"/m/hq/s/WXXWY","defaultTab":"news","newsList":[{"id":"2586403694","title":"美国OTC市场药明生物ADR盘中异动 股价大涨5.75%报8.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586403694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586403694?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:46","pubTimestamp":1763995604,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时46分,美国OTC市场药明生物ADR股票出现异动,股价大幅拉升5.75%。截至发稿,该股报8.28美元/股,成交量1811股,换手率0.00%,振幅0.13%。美国OTC市场药明生物ADR股票所在的生物技术行业中,整体涨幅为0.54%。美国OTC市场药明生物ADR公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124224644a70e9087&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124224644a70e9087&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2575695253","title":"美国OTC市场药明生物ADR盘中异动 早盘急速拉升6.41%报9.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575695253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575695253?lang=zh_cn&edition=full","pubTime":"2025-10-13 22:36","pubTimestamp":1760366180,"startTime":"0","endTime":"0","summary":"北京时间2025年10月13日22时36分,美国OTC市场药明生物ADR股票出现波动,股价快速拉升6.41%。截至发稿,该股报9.63美元/股,成交量416股,换手率0.00%,振幅1.77%。美国OTC市场药明生物ADR股票所在的生物技术行业中,整体涨幅为0.31%。美国OTC市场药明生物ADR公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101322362094c6b615&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101322362094c6b615&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2574690437","title":"美国OTC市场药明生物ADR盘中异动 早盘大幅下挫5.38%报9.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574690437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574690437?lang=zh_cn&edition=full","pubTime":"2025-10-10 21:46","pubTimestamp":1760103988,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日21时46分,美国OTC市场药明生物ADR股票出现异动,股价急速下跌5.38%。截至发稿,该股报9.84美元/股,成交量4812股,换手率0.00%,振幅0.48%。美国OTC市场药明生物ADR股票所在的生物技术行业中,整体跌幅为0.28%。美国OTC市场药明生物ADR公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010214628a6b319bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010214628a6b319bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2571655463","title":"美国OTC市场药明生物ADR盘中异动 股价大涨5.59%报10.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571655463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571655463?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:42","pubTimestamp":1759156922,"startTime":"0","endTime":"0","summary":"北京时间2025年09月29日22时42分,美国OTC市场药明生物ADR股票出现波动,股价大幅上涨5.59%。截至发稿,该股报10.58美元/股,成交量251股,换手率0.00%,振幅0.00%。美国OTC市场药明生物ADR股票所在的生物技术行业中,整体涨幅为1.81%。美国OTC市场药明生物ADR公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929224202a6a68537&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929224202a6a68537&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2558643957","title":"药明生物ADR8月11日成交额为3.98万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558643957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558643957?lang=zh_cn&edition=full","pubTime":"2025-08-12 16:37","pubTimestamp":1754987871,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日,药明生物ADR成交额为3.98万美元,成交额较昨日减少85.67%,当日成交量为5280.00股。药明生物ADR于2025年8月11日涨0.8%,报7.56美元,该股过去5个交易日跌4.3%,年初至今涨70.65%,过去60日涨25.79%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812172909a483cece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812172909a483cece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2558219509","title":"药明生物ADR8月8日成交额为27.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558219509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558219509?lang=zh_cn&edition=full","pubTime":"2025-08-09 16:36","pubTimestamp":1754728576,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日,药明生物ADR成交额为27.78万美元,成交额较昨日减少38.96%,当日成交量为3.71万股。药明生物ADR于2025年8月8日跌2.22%,报7.5美元,该股过去5个交易日跌4.21%,年初至今涨69.3%,过去60日涨27.12%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809163621a6dc4f9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809163621a6dc4f9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2557523564","title":"药明生物ADR8月7日成交额为45.51万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557523564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557523564?lang=zh_cn&edition=full","pubTime":"2025-08-08 16:31","pubTimestamp":1754641891,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日,药明生物ADR成交额为45.51万美元,成交额较昨日增加113.37%,当日成交量为5.91万股。药明生物ADR于2025年8月7日跌4.01%,报7.67美元,该股过去5个交易日跌6.12%,年初至今涨73.14%,过去60日涨28.05%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808180511a47d074e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808180511a47d074e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2557313562","title":"美国OTC市场药明生物ADR盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557313562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557313562?lang=zh_cn&edition=full","pubTime":"2025-08-07 22:39","pubTimestamp":1754577581,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日22时39分,美国OTC市场药明生物ADR股票出现波动,股价急速下挫5.26%。美国OTC市场药明生物ADR股票所在的生物技术行业中,整体跌幅为0.17%。美国OTC市场药明生物ADR公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080722394194d5bb0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080722394194d5bb0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2557563915","title":"药明生物ADR8月6日成交额为21.33万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557563915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557563915?lang=zh_cn&edition=full","pubTime":"2025-08-07 16:23","pubTimestamp":1754555032,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日,药明生物ADR成交额为21.33万美元,成交额较昨日增加81.62%,当日成交量为2.67万股。药明生物ADR于2025年8月6日跌0.5%,报7.99美元,该股过去5个交易日跌2.92%,年初至今涨80.36%,过去60日涨36.58%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807173053a47aa04b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807173053a47aa04b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2557324838","title":"药明生物ADR8月5日成交额为11.74万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557324838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557324838?lang=zh_cn&edition=full","pubTime":"2025-08-06 16:14","pubTimestamp":1754468064,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日,药明生物ADR成交额为11.74万美元,成交额较昨日增加12.57%,当日成交量为1.45万股。药明生物ADR于2025年8月5日涨1.65%,报8.03美元,该股过去5个交易日跌4.63%,年初至今涨81.26%,过去60日涨39.65%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806165519a6d63313&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806165519a6d63313&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2557178318","title":"美国OTC市场药明生物ADR盘中异动 早盘股价大涨6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557178318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557178318?lang=zh_cn&edition=full","pubTime":"2025-08-05 23:08","pubTimestamp":1754406487,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日23时08分,美国OTC市场药明生物ADR股票出现波动,股价大幅拉升6.33%。美国OTC市场药明生物ADR股票所在的生物技术行业中,整体跌幅为3.31%。美国OTC市场药明生物ADR公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080523080794d186a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080523080794d186a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2557361840","title":"药明生物ADR8月4日成交额为10.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557361840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557361840?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:13","pubTimestamp":1754381587,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日,药明生物ADR成交额为10.43万美元,成交额较昨日减少16.21%,当日成交量为1.31万股。药明生物ADR于2025年8月4日涨0.89%,报7.9美元,该股过去5个交易日跌1.86%,年初至今涨78.33%,过去60日涨41.32%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805164400a6d41e8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805164400a6d41e8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2556817801","title":"美国OTC市场药明生物ADR盘中异动 急速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556817801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556817801?lang=zh_cn&edition=full","pubTime":"2025-08-01 23:11","pubTimestamp":1754061075,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日23时11分,美国OTC市场药明生物ADR股票出现异动,股价快速下挫5.05%。美国OTC市场药明生物ADR股票所在的生物技术行业中,整体跌幅为0.03%。美国OTC市场药明生物ADR公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801231115a6ce10d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801231115a6ce10d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2556896408","title":"药明生物ADR7月31日成交额为11.51万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556896408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556896408?lang=zh_cn&edition=full","pubTime":"2025-08-01 16:37","pubTimestamp":1754037455,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日,药明生物ADR成交额为11.51万美元,成交额较昨日减少41.57%,当日成交量为1.43万股。药明生物ADR于2025年7月31日跌0.73%,报8.17美元,该股过去5个交易日涨7.5%,年初至今涨84.42%,过去60日涨31.99%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801172511a6cd7ea7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801172511a6cd7ea7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2555010360","title":"药明生物ADR7月29日成交额为111.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555010360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555010360?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:48","pubTimestamp":1753865311,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日,药明生物ADR成交额为111.64万美元,成交额较昨日增加923.10%,当日成交量为13.28万股。药明生物ADR于2025年7月29日涨4.6%,报8.42美元,该股过去5个交易日涨18.09%,年初至今涨90.07%,过去60日涨45.17%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730172626a46b5107&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730172626a46b5107&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2555378410","title":"药明生物ADR7月28日成交额为10.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555378410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555378410?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:43","pubTimestamp":1753778602,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日,药明生物ADR成交额为10.91万美元,成交额较昨日减少61.72%,当日成交量为1.35万股。药明生物ADR于2025年7月28日涨1.0%,报8.05美元,该股过去5个交易日涨13.06%,年初至今涨81.72%,过去60日涨40.73%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729172418a46962a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729172418a46962a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2553226325","title":"药明生物:预计上半年归属权益股东的利润同比增长56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553226325","media":"第一财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553226325?lang=zh_cn&edition=full","pubTime":"2025-07-24 07:12","pubTimestamp":1753312326,"startTime":"0","endTime":"0","summary":"药明生物在港交所公告,预期与去年同期比较,2025年上半年收益将增长约16%,毛利率将同比提升约3.6%;上半年利润及归属于公司权益股东的利润相比于去年同期将分别增长约54%和约56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724071234954f8902&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724071234954f8902&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2552087487","title":"美国OTC市场药明生物ADR盘中异动 早盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552087487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552087487?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:37","pubTimestamp":1752763062,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时37分,美国OTC市场药明生物ADR股票出现波动,股价急速上涨5.15%。美国OTC市场药明生物ADR股票所在的生物技术行业中,整体涨幅为0.18%。美国OTC市场药明生物ADR公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071722374297a9e556&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071722374297a9e556&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2552048909","title":"药明生物ADR7月16日成交额为5.94万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552048909","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552048909?lang=zh_cn&edition=full","pubTime":"2025-07-17 15:59","pubTimestamp":1752739168,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日,药明生物ADR成交额为5.94万美元,成交额较昨日减少9.87%,当日成交量为8639.00股。药明生物ADR于2025年7月16日跌0.15%,报6.8美元,该股过去5个交易日涨6.58%,年初至今涨53.5%,过去60日涨31.53%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717164325a6af546d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717164325a6af546d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2551619342","title":"药明生物ADR7月14日成交额为8.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551619342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551619342?lang=zh_cn&edition=full","pubTime":"2025-07-15 16:18","pubTimestamp":1752567490,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日,药明生物ADR成交额为8.99万美元,成交额较昨日减少53.41%,当日成交量为1.32万股。药明生物ADR于2025年7月14日涨1.04%,报6.83美元,该股过去5个交易日涨8.07%,年初至今涨54.18%,过去60日涨26.01%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715170703a44bf217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715170703a44bf217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":0.0455},{"period":"1month","weight":0.056},{"period":"3month","weight":0.1404},{"period":"6month","weight":0.0218},{"period":"1year","weight":0.2475},{"period":"ytd","weight":0.6829}],"description":"药明生物技术有限公司是一家主要从事向生物制剂行业的客户提供就生物发现、开发及生产的端到端解决方案及服务的投资控股公司。该公司主要通过两个分部运营其业务。生物药分部主要从事提供生物药的发现、开发和生产。药明合联(XDC)分部主要从事为抗体偶联药物(ADCs)及各种生物偶联药物提供合同研究、开发及生产组织(CRDMO)服务。该公司主要在国内和国外市场开展其业务。","exchange":"PINK LIMITED","name":"药明生物ADR","nameEN":"Wuxi Biologics (Cayman) Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明生物ADR(WXXWY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明生物ADR(WXXWY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明生物ADR,WXXWY,药明生物ADR股票,药明生物ADR股票老虎,药明生物ADR股票老虎国际,药明生物ADR行情,药明生物ADR股票行情,药明生物ADR股价,药明生物ADR股市,药明生物ADR股票价格,药明生物ADR股票交易,药明生物ADR股票购买,药明生物ADR股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明生物ADR(WXXWY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明生物ADR(WXXWY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}